Europe – Post-authorisation : Grouping of Variations – Q & A

This page lists questions that marketing-authorisation holders (MAHs) may have on grouping of variations. It provides an overview of the European Medicines Agency’s position on issues that are typically addressed in discussions or meetings with MAHs in the post-authorisation phase. Revised topics are marked ‘New’ or ‘Rev.’ upon publication…